Transcript Highlights:

• And one last thing on numbers: FDA set regulations for salmonella several years ago, actually over a
• Well, that's why FDA has the food salmonella enteritidis rule.
• You're trying to fall under that 3,000 of FDA so you don't have to test your birds for salmonella, as
• There are no requirements for FDA guidelines. No CDC guidelines have to be followed.
• No FDA, no informed consent, and all of this is still present in our federal laws.

Bills: SB500, SB719, SB912, SB1232, SB1467, SB1777, SB1864, SB2023, SB2119, SB2458

Keywords: SB 500, Texas adoption law, Family Code, DFPS, Department of Family and Protective Services, child-placing agency, prospective adoptive parents, adoption records, confidential information, nondisclosure agreement, child history report, health history, social history, educational history, genetic history, termination of parental rights, permanency plan, single source continuum contractor, privacy, redaction

Summary: The committee first took up several pending bills and reported them favorably: SB 968, SB 636 as substituted, SB 1137, and SB 1138 as substituted. Each was advanced by roll call vote, and the committee also recommended the approved bills for the local and uncontested calendar. The chair then moved to the posted agenda and heard SB 719, a mental health bed-capacity study bill by Senator Eckhart, with a committee substitute that refined the data collection to distinguish state and non-state beds, child and adult beds, include two point-in-time counts, and capture jail diversion data. Testimony on SB 719 was largely supportive from Integral Care, NAMI Texas, and the Children’s Hospital Association of Texas, all of whom said Texas needs better data on inpatient psychiatric capacity, workforce needs, and future demand. Several witnesses described long waits for beds, especially for forensic restoration, and argued the study would help target future investments. Senator Perry and others noted the state has already made major investments in new beds and urged the bill to account for beds already coming online; the committee ultimately withdrew the substitute and left SB 719 pending after public testimony closed. The committee then heard SB 1864, which would allow small egg producers to sell ungraded eggs more broadly, including to restaurants and retailers, with the substitute increasing the weekly sales threshold and addressing sanitation and labeling. Supporters said grading is about size, not safety, and that the bill would help small farms reach new markets; opponents from the Texas Poultry Federation argued grading and candling help identify cracks and defects that can affect safety and quality. The committee adopted the substitute and left the bill pending. It also heard SB 1467, requiring DSHS to share death record information with hospitals for record accuracy and quality review, and SB 912, which would modernize continuing education tracking for health licensing agencies; both bills drew supportive testimony and were left pending. Finally, the committee heard SB 2023, which would create an HHSC grant program to help counties pay for indigent burial costs, with county representatives testifying in support.

Transcript Highlights:

• How would the law work with the rules of the FDA? Page 10 has rules on labeling.
• These rules conflict at all with FDA rules?
• The FDA on their website has this statement.
• by the FDA, the amendment references FDA approved products and states that those are legal products.
• On May 8, 2025, the chairman of the FDA,...

Bills: SB6, SB30, SB13, SB2878, SB2501, SB66, SB268, SB331, SB618, SB414, SB1394, SB2425, SB898, SB993, SB442, SB735, SB784, SB2538, SB1919, SB1013, SB2215, SB2322, SB626, SB570, SB747, SB2183, SB673, SB1015, SB1447, SB1370, SB1784, SB1897, SB2873, SB2891, SB2933, SB2540, SB2681, SB2695, SB1965, SB2203, SB872, SB875, SB1030, SB1277, SB1730, SB1681, SB1152, SB2969, SB2747, SB2705, SB2541, SB1708, SB2080, SB2721, SB1986, SB2392, SB2539, SB2857, SB2799, SB2785, SB2782, SB1531, SB1927, SB1263, SB1098, SB835, SB3070, SB22, SJR27, SB25, SB7, SB552, SB1612, SJR87, SJR1, SB6, SB30, SB13, SB2878, SB57, SB127, SB293, SB441, SB3059, SB512, SB241, SB1718, SB140, SB2055, SB2075, SB2018, SB1534, SB1567, SB785, SB1233, SB1580, SB1663, SB413, SB447, SB519, SB467, SB1579, SB1191, SB1021, SB1838, SB2807, SB2835, SB546, SB2121, SB2167, SB2035, SB2024, SB1032, SB1049, SB1266, SB1400, SB1302, SB401, SB1596, SB1281, SB1242, SB1343, SB310, SB1346, SB2753, SB2703, SB2221, SB1719, SB2177, SB800, SB790, SB748, SB571, SB1957, SB1923, SB1896, SB1760, SB1335, SB2368, SB2477, SB2587, SB2972, SB2986, SB2965, SB1563, SB1467, SB1164, SB1137, SB614, SB705, SB961, SB918, SB955, SB869, SB850, SB863, SB1610, SB1055, SB2206, SB457, SB2337, SB1362, SB926, SB1494, SB251, SB456, SB500, SB1307, SB2615, SB2995, SB2321, SB973, SB974, SB865, SB506, SB781, SB1522, SB1558, SB510, SB667, SB763, SB2073, SB1858, SB1660, SB505, SB2900, SB1433, SB1540, SB1964, SB1300, SB1644, SB2217, SB2373, SB2431, SB1758, SB2480, SB3039, SB3047, SB3073, SB2920, SB2781, SB826, SB766, SB2460, SB527, SB1946, SB2885, SB1243, SB2610, SB2595, SB857, SB2501, SB66, SB268, SB331, SB618, SB414, SB1394, SB2425, SB898, SB993, SB442, SB735, SB784, SB2538, SB1919, SB1013, SB2215, SB2322, SB626, SB570, SB747, SB2183, SB673, SB1015, SB1447, SB1370, SB1784, SB1897, SB2873, SB2891, SB2933, SB2540, SB2681, SB2695, SB1965, SB2203, SB872, SB875, SB1030, SB1277, SB1730, SB1681, SB1152, SB2969, SB2747, SB2705, SB2541, SB1708, SB2080, SB2721, SB1986, SB2392, SB2539, SB2857, SB2799, SB2785, SB2782, SB1531, SB1927, SB1263, SB1098, SCR9, HB5560, HB762, HB 107, HB 114, HB138, HB4386, HB2495, HB581, HB3348, HB5323, HB1584, HB4341, HB6, HB171, HB143, HB449, HB3486, HB4263, HB5246, HB2, HB2011, SB17, SB21

Keywords: electric power, interconnection, utilities, ERCOT, large load customers, water supply, sewer service, demand management, school libraries, library advisory councils, parental rights, library materials, educational content, challenging materials, judicial branch, court security, expunction, pretrial intervention, youth diversion, record retention

Transcript Highlights:

• in how devices are not just created safely but also marketed wisely and so the gap between when the FDA
• FDA to approve the device that would save lives, it turns out, with clinical trials proving this. money
• your point, we should make it easier for industry. to create life-saving tools by aligning when the FDA
• One of the things that I've emphasized is the importance of getting faster coverage through the FDA for

Keywords: Michael Falkender, Deputy Secretary of the Treasury, IRS, taxpayer privacy, nomination process, committee hearing

Summary: The committee convened to discuss critical issues surrounding the nomination of Michael Falkender for the position of Deputy Secretary of the Treasury. This meeting included a series of remarks from committee members who expressed divergent views on Falkender's qualifications and the implications of his appointment. Senator Wyden voiced strong opposition, arguing that Falkender represents harmful policies expected to be perpetuated under the current administration, especially concerning taxpayer privacy and IRS tactics. Meanwhile, other members defended Falkender, noting his extensive experience, including a commitment to transparency in government operations if confirmed.

Transcript Highlights:

• It has been FDA-approved for 25 years and has continuously proven to be safe by institutions such as
• According to the FDA, several U.S. women who used the abortion pill died due to overwhelming total body
• As mentioned earlier, a 2016 study found that the FDA no longer...
• The FDA warns that drugs from outside the U.S. supply chain bypass crucial safety safeguards.
• Non-FDA drugs are illegal. Giving someone drugs without their consent is illegal.

Bills: HB229, HB229, HB3990, HB5082, HB5510

Keywords: HB 229, Texas, political subdivision, local government, county dues, county association, state association of counties, lobbying, lobbyist, public funds, taxpayer lawsuit, injunctive relief, attorney's fees, Government Code Chapter 556, Local Government Code Section 89.002, legislative advocacy, municipal government, county government, city government, special district

Transcript Highlights:

• That the non-tobacco product was properly filed and accepted by the FDA by the deadline of May 14th,
• The product remains under review by the FDA.

Bills: HB227, HB255, HB465, HB472, HB482, HB483, HB526, HB529, HB484

Keywords: firefighter benefits, occupational disease, line of duty, disability pension, death benefits, retirement benefits, hypertension, heart disease, respiratory disease, cancer presumption, HIV, hepatitis, municipal firefighters, state firefighters, fire districts, workers' compensation, public safety employees, post-retirement benefits, benefit eligibility cutoff, occupational illness

Transcript Highlights:

• Biosimilars undergo extensive FDA review and have been shown to be safe, effective, and clinically equivalent
• have some questions because the original biosimilar bill was presented by me many years ago, when the FDA
• And the FDA had not necessarily regulated biosimilars, but we knew that for chronic illnesses we needed

Summary: The committee heard several bills, but much of the meeting focused on House Bill 306, which would require disclosure when a consumer is interacting with a chatbot rather than a human. Sponsor Senator Townsend described it as a consumer protection measure and said the bill is meant to keep pace with rapidly changing AI technology. Committee members and witnesses raised concerns about the bill’s enforcement structure, especially private rights of action and penalties that could apply even without actual consumer harm. The Department of Justice said the bill would apply where the conduct has a Delaware nexus, and that the disclosure requirement is the key consumer protection. Industry witnesses and chambers of commerce opposed the bill as drafted, arguing it would create broad compliance burdens and expose businesses to excessive litigation risk without a harm requirement or clearer safe harbor language. Earlier in the meeting, the committee discussed House Bill 429, which would update Delaware’s step therapy exception process to include biosimilars and interchangeable biologics. Senator Poore and supporters from Highmark and the Department of Insurance said the bill would modernize insurance law, improve access to effective treatments, and reduce costs; they cited national savings from biosimilars and said the bill has agency support. Members asked about Delaware-specific savings, patient switching, and how the process would work, but no vote was taken during the discussion. The committee also heard House Bill 310, which would exclude large data centers from Blue Collar Jobs Act tax credits; the sponsor said the bill is intended to ensure large energy users contribute more to state and local revenues, while supporters and opponents debated competitiveness and community impacts. House Bill 406, on allowing insureds to choose their auto repair shop, and Senate Bill 347, a cleanup bill related to medical debt collection and personal property levies, were also presented without opposition in the hearing. House Bill 253, concerning who may receive letters testamentary or of administration, was described as a cleanup to align statute with existing practice. The committee approved the meeting minutes, but the transcript does not show final votes on the bills discussed.

Transcript Highlights:

• Despite not being approved by the FDA for any reason— Despite not being approved by the FDA for any reason
• AB 1906 would require coverage for at-home cervical cancer screening kits, which were recently FDA approved

Keywords: 987, senate, all

Transcript Highlights:

• and access to vaccines in our state, and vaccines that are based in the science and evidence that the FDA
• FDA authorization changes, particularly how that impacts access to vaccines, ...particularly how that
• FDA authorization changes particularly how how that impacts access to vaccines. particularly how that

Summary: The committee first welcomed new DSHS Secretary Angela Ramirez, who introduced herself and described her background in public service, federal and state legislative work, and health and human services leadership. Members emphasized the importance of building strong relationships with her and noted her focus on protecting services, using strategic approaches in a tight budget environment, and improving partnerships with the Legislature. Ramirez said she wanted to keep communication open and that her priorities would be shaped by what she learns from lawmakers and agency partners. The next work session focused on the West Coast Health Alliance and the broader Governor’s Public Health Alliance. Department of Health and governor’s office staff said the West Coast alliance, involving Washington, Oregon, California, and Hawaii, was formed to coordinate science-based public health guidance, especially around vaccines, return-to-work guidance, and responses to federal changes. They said the alliance is intended to reduce confusion, counter misinformation, and preserve access to evidence-based recommendations, with early actions including vaccine guidance for COVID-19, flu, and RSV, a statement rejecting any vaccine-autism link, and preparation for possible ACIP changes. Members asked about workload and coordination with other regional alliances, and staff said there is informal coordination but no formal regular meetings. The committee then heard from the Washington State Health Benefit Exchange about open enrollment and the effects of federal policy changes. Exchange leaders said the expiration of enhanced premium tax credits, HR1 provisions, and immigration-related eligibility changes are affecting affordability and enrollment, with some customers facing large premium increases and some counties becoming harder to serve. They reported early open-enrollment traffic increases, nearly 10,000 new sign-ups, and nearly 12,000 active coverage drops so far, while noting that many more people may disenroll later if subsidies are not extended. They also described mitigation efforts such as silver loading, Cascade Care Savings, outreach through navigators and community partners, and planning for future HR1 requirements like ending auto-renewal and adding verification steps. In the final work session, staff from the Health Care Authority and Insurance Commissioner’s office reviewed Washington’s health reform history and the state’s current affordability and access efforts. They highlighted past ACA-related coverage gains, continued work on prescription drug affordability, PBM oversight, primary care and behavioral health access, and a pending legislative proposal to preserve access to preventive services. They also discussed federal changes affecting Medicaid and the exchange, including work requirements, six-month redeterminations, and the need to coordinate across agencies to implement new rules. Members raised concerns about network adequacy, provider access, and the complexity of the health care system, while staff said they are trying to mitigate harm, simplify administration, and keep coverage and access as stable as possible.

Transcript Highlights:

• :08:14.240> uh<00:08:14.400> safety<00:08:14.800> inspection,<00:08:16.080> FDA
• ,<00:08:16.720> EPA,<00:08:17.280> but food uh safety inspection, FDA, EPA, but food
• uh safety inspection, FDA, EPA, but also<00:08:17.759> like<00:08:17.919> forest<00:08
• We're also seeing some efforts by FDA to give us more pharmaceuticals to treat these with.
• > fasttracked<01:01:51.359> some the FDA has has fasttracked some the FDA has has fasttracked

Keywords: 1183, house

Transcript Highlights:

• I think you're referring to, like, stacking of the requirements: FDA-approved approval timeline, state
• workforce eligibility requirements, would they revoke the approval after it's already been granted by the FDA
• FDA approved approval timeline, state federal government permitting.
• workforce eligibility requirements, would they revoke the approval after it's already been granted by the FDA

Keywords: 988, house, all

Transcript Highlights:

• They were essentially our means of determining what drugs that have been FDA-approved should... ...means
• of determining what drugs that have been FDA-approved should be available to patients.
• That's another FDA indication that we cover for, and we also cover for MASH, which is non-alcoholic fatty
• question is, since you guys are only treating or you're only covering GLP-1s for diabetes and for the FDA

Keywords: 1184, house, all

Transcript Highlights:

• services, APHIS, which works with the plant and animals, FSIS, which is our food safety inspection, FDA
• FSIS, which is our food uh safety uh FSIS, which is our food uh safety inspection,<00:04:40.800> FDA
• > EPA,<00:04:42.080> but<00:04:42.320> also<00:04:42.479> like inspection, FDA
• , EPA, but also like inspection, FDA, EPA, but also like forest<00:04:43.120> service,<00:04:43.440

Keywords: 919, house, all

Summary: The Minnesota Department of Agriculture presented an overview of its budget, staffing, and major program areas, including protection services, marketing, and administration. Commissioners also highlighted concerns about federal funding uncertainty after a January letter suspending active and future USDA awards to the department. They said the issue affected about 13% of the agency’s budget, created confusion for farmers, and briefly disrupted poultry lab testing and HPAI-related work, though they later received assurances from USDA leadership that existing programs would continue processing. The department also described its anti-fraud efforts, including internal controls, a compliance coordinator, a grants administrator, review committees, site visits, and participation in the state’s Inspector General Coordinating Council. The committee then discussed several agriculture support programs. For dairy margin coverage, the department said Minnesota’s sign-up is open and supported a bill to extend assistance to farmers who began operations in 2023-2025 and were not covered under the earlier production-based formula. The renamed Farm to Food Security program, formerly LFPA, was described as a state-created local food purchasing effort funded at $700,000 per year. The down payment assistance grant for first-time farm buyers was also reviewed; the department said it has supported 112 farmers so far, with additional awards pending, but noted timing problems when purchase agreements fall through. Members asked whether priority should be given to applicants with signed purchase agreements, and the department said that was under consideration. The grain indemnity account update focused on the Hansen-Mueller facility failure and related claims. The department said the account holds about $10.7 million, has received 19 claims totaling $1.1 million, and that $842,000 of those claims were tied specifically to Minnesota transactions. It explained the difference by noting that some claims involved Minnesota farmers selling in North Dakota and Wisconsin, and that the indemnity account covers grains sold in Minnesota. The committee also heard updates on elk and wolf depredation payments, with the department projecting shortfalls in both funds and noting that payments are being delayed into later months. The agriculture response fund balance was said to be about $2.5 million. Finally, the Rural Finance Authority and the East Grand Forks potato facility were discussed. The RFA reported strong demand for low-interest loans, about $26 million remaining from the prior $50 million authorization, and a new $50 million bonding request in the governor’s proposal to avoid a funding gap. The department said the program has issued 3,951 loans totaling about $390.3 million with very low defaults. It also requested $1.38 million in bonding for building improvements at the East Grand Forks potato facility, which it said is the department’s only owned building and supports a significant potato industry. In response to a question from Rep. Bang, the commissioner said recent ICE activity had affected farms, processing plants, immigrant workers, and some rural food businesses, and that the department had relayed those concerns to the governor’s office and congressional delegation.

Transcript Highlights:

• Wheelchairs are highly specialized FDA-regulated medical devices. They're not mass-produced.
• Wheelchairs [snorts] are highly<00:13:26.639> specialized<00:13:27.360> FDA<00:13:27.920
• > regulated<00:13:28.399> medical highly specialized FDA regulated medical highly specialized
• FDA regulated medical devices.<00:13:29.279> They're<00:13:29.519> not<00:13:29.760>

Bills: HB1849, HB2000, HB1753, HB1511, HB276, HB1513, HB2188, HB1876

Keywords: licensing, professional license, individual taxpayer identification number, immigration, state residency, right to repair, wheelchairs, consumer protection, repair providers, device documentation, HB1753, Hawaii Social Media Data Deletion Act, social media, account deletion, data deletion, privacy, consumer privacy, personal information, sensitive personal information, data retention

Summary: The committee on Consumer Protection and Commerce met on February 10, 2026, and heard testimony on several bills. HB 1849 relating to licensing drew comments from DCCA’s Professional and Vocational Licensing Division and the Hawaii Real Estate Commission, both of which stood on written testimony. The Hawaii Coalition for Immigrant Rights testified in strong support, emphasizing that some immigrants, including DACA recipients, are already contributing in Hawaii and that the state should help create pathways for them to remain and advance professionally. No vote or final action was taken on HB 1849 during the portion shown. The committee then heard HB 2000, the wheelchair right-to-repair bill. Encart opposed the measure, arguing that repair delays are largely driven by insurance prior authorization and that wheelchair repairs involve FDA-regulated medical devices where improper repairs could create health risks. Peter Fritz testified in support, saying the bill was modeled on similar laws in other states and that he had personal experience through his sister’s use of a wheelchair. Members questioned whether repairs done outside insurer networks might not be reimbursed, and Fritz said that was a concern but that the need for timely repair outweighed it. The committee also discussed HB 1753 on social media, where DCCA’s Office of Consumer Protection supported the bill but suggested an amendment to the definition of personal information. On HB 1511 relating to consumer protection, DCCA’s Insurance Division supported the bill, while the Alliance for Automotive Innovation and the Hawaii Automobile Dealers Association offered comments seeking to preserve legitimate manufacturer and dealer communications about vehicles, warranties, recalls, and related services. The committee also took up HB 276 HD1 and HB 1513 on condominiums. The Hawaii Real Estate Commission offered comments on HB 276 HD1. For HB 1513, the Hawaii Green Infrastructure Authority supported the bill, but DCCA’s Insurance Division opposed it, warning that diverting HHRF funds could weaken reinsurance arrangements and raise premiums for consumers who rely on the fund. Members questioned whether the proposed condo loan program would need HHRF money and whether the amounts in the bill were necessary, and the division said it opposed using HHRF for that purpose. The committee also heard HB 2188 on housing, where OCP supported the measure and the Hawaii Association of Realtors raised concerns about conflicts with the Fair Credit Reporting Act and the use of tenant screening reports, noting that a working group is already addressing landlord-tenant issues. Members asked OCP to research how other states handle similar laws and whether additional language is needed to avoid federal conflict. Finally, on HB 1876 relating to mental health, the Department of Health’s Adult Mental Health Division supported the bill but said it remains opposed to harmful, non-evidence-based treatment modalities; Pride at Work Hawaii also testified in strong support. No final votes or committee decisions were reported in the excerpt.

Transcript Highlights:

• And none of those products have sought FDA. ...approval, Representative Tinderholt, none of them.
• And so none of them have not only sought approval, they have not received FDA approval.
• talked about before about the whole. ...whole piece on the certifications where you talked about the FDA
• So now is there any FDA approval required for these? Yes, of course. We are banning.

Bills: HCR158, HCR159, HCR160, HCR161, HCR162, HCR163, HCR164, HR174, HR427, HR790, HR810, HR857, HR866, HR882, HR883, HR962, HR966, HR1001, HR1045, HR1085, HR1097, HR1127, HR1138, HR1141, HR1150, HR1152, HR1292, HR1296, HR1304, HR1305, HR1306, HR1308, HR1309, HR1310, HR1311, HR1312, HR1313, HR1315, HR1317, HR1318, HR1320, HR1321, HR1322, HR1323, HR1324, HR1325, HR1327, HR1328, HR1329, HR1330, HR1331, HR1332, HR1333, HR1334, HR1335, HR1338, HR1340, HR1341, HR1342, HR1343, HR1344, HR1345, HR1346, HR1347, HR1348, HR1349, HR1352, HR1353, HR1354, HR1355, HR1358, HR1359, HR1360, HR1361, HR1362, HR1363, HR1364, HR1365, HR1366, HR1368, HR1369, HR1370, HR1380, HR1383, HR1384, HR1385, HR1386, HR1387, HR1388, HR1389, HR1390, HR1392, HR1393, HR1396, HR1397, HR1398, HR1399, HR1400, HR1402, HR1403, HR1404, HR1405, HR1406, HR1407, HR1408, HR1409, HR1410, HR1411, HR1412, HR1413, HR1414, HR1415, HR1417, HR1418, HR1419, HR1420, HR1421, HR1422, HR1424, HR1425, HR1426, HR1427, HR1428, HR1429, HR1430, HR1431, HR1432, HR1433, HR1434, HR1435, HR1436, HR1437, HR1438, HR1440, HR1441, HR1442, HR1443, HR1444, HR1445, HR1447, HR1448, HR1449, HR1450, HR1452, HR1453, HR1454, HR1455, HR1456, HR1458, HR1459, HR1460, HR1461, HR1462, HR1463, HR1464, HR1465, HR1466, HR1467, HR1469, HR1470, HR1471, HR1472, HR1473, HR1475, HR1477, HCR132, HCR154, HR17, HR49, HR170, HR275, HR355, HR356, HR364, HR369, HR672, HR690, HR755, HR756, HR759, HR762, HR763, HR781, HR785, HR848, HR1240, HR1265, HR1303, HR1307, HR1314, HR1316, HR1319, HR1326, HR1336, HR1337, HR1350, HR1351, HR1367, HR1371, HR1372, HR1373, HR1374, HR1375, HR1376, HR1377, HR1378, HR1379, HR1382, HR1391, HR1395, HR1451, HR1457, HR1468, HR1474, HR1476, SB1637, SB2878, HB2885, HB2017, HB5246, SB8, SB2308, SB1405, HB 119, SB3059, SB15, SB568, SB2900, HB3642, HB3909, SB268, HB493, SB2217, HB2516, SB650, HB2963, SB1610, HB705, SB2972, SB1540, HB40, SB2753, SB1660, SB2024, HB1545, HB46

Keywords: World War II, V-J Day, Victory over Japan Day, Japan surrender, atomic bomb, Hiroshima, Nagasaki, USS Missouri, Douglas MacArthur, Harry S. Truman, Winston Churchill, Joseph Stalin, Potsdam Conference, Pacific Theater, Greatest Generation, veterans, military history, commemoration, concurrent resolution, Texas Legislature

Transcript Highlights:

• the bill does is let physicians treat patients with stem cell therapies that are not approved by the FDA
• the bill does is let physicians treat patients with stem cell therapies that are not approved by the FDA
• And additionally, the FDA regulates biologics used in transplantation, and this includes ensuring the
• The bill concerns only stem cell therapy not approved by the FDA. Thank you for the question.

Summary: The Senate opened with prayer, the Pledge of Allegiance, and a series of member introductions recognizing interns, pages, volunteers, and the retirement of Pastor Gary Austin from the sergeant’s office. Leadership also announced that budget talks with the House were continuing and that senators would not need to plan on being in next week, suggesting progress toward a budget framework. After routine floor business, the chamber took up a major third-reading measure on citizen initiatives and several education bills, followed later by returning messages from the House on health and school-safety measures. The most extensive debate centered on the citizen initiative bill, which sponsors said was intended to protect the constitutional amendment process from fraud and abuse based on election-crime investigations and a large state report on petition fraud. Supporters argued the bill would add reasonable guardrails, prevent misuse of public funds, and preserve integrity while still allowing grassroots participation. Opponents from both parties argued it would make citizen-led amendments much harder by adding costs, deadlines, criminal penalties, and administrative burdens that would chill participation and favor wealthy or corporate interests. After lengthy debate, the Senate voted 28-10 to pass the bill. The chamber then passed several education measures with little or no opposition, including bills tied to Bright Futures, dual enrollment, Florida ABLE, teacher preparation, and other education policy updates, all by 38-0. Later, the Senate concurred in House amendments on a stem cell therapy bill, an EKG requirement for student athletes, and a cardiac emergency bill, each passing 37-0. The House also sent back a school safety bill with amendments affecting child care facility partnerships with law enforcement, temporary door locks during active assailant incidents, supervision windows, and funding for panic alarm systems; the transcript ends as that bill is being explained.

Transcript Highlights:

• When you combine these losses at the state level with those at CDC and FDA, we are no longer able to
• with those at losses at the state level with those at CDC<00:07:47.280> and<00:07:47.599> FDA
• 48.560> no<00:07:48.720> longer<00:07:49.120> able<00:07:49.599> to CDC and FDA
• , we are no longer able to CDC and FDA, we are no longer able to investigate<00:07:50.639> the

Keywords: 919, house, all

Summary: Sen. Erin Maye Quade, Rep. Esther Abad, and other Minnesota DFL legislators held a press event focused on responding to Trump administration and federal Republican actions that they said threaten health care, education, housing, public health, and other state services. Speakers argued Minnesota must not make “false trade-offs” between core services and should instead protect programs like Medicaid, school funding, disability services, nutrition, and public health by raising additional revenue and closing tax breaks for wealthy individuals and corporations. Rep. Abad and others outlined possible revenue options, including a fifth-tier income tax, a corporate rate match, closing tax exemptions for luxury items and second homes, a social media tax, and ending data center tax exemptions. They said these measures would not fully replace possible federal cuts, but could help mitigate harm and preserve services. Several speakers also criticized Republican opposition to tax increases and said the state should ask wealthy taxpayers and corporations to contribute more. Testimony from Olivia Dylan, a laid-off Minnesota Department of Health epidemiologist, described the impact of federal public health funding cuts and MDH layoffs on outbreak response, nursing home support, lab work, and tribal public health. Sean Leaden of SEIU Local 284 described low pay and staffing shortages among hourly school workers and said underfunding has hurt students and employees. Sen. Doran Clark and Rep. Emma Greenman framed the issue as both a budget and democracy question, arguing that federal cuts and attacks on public programs undermine self-governance and community well-being. In response to questions, speakers said Minnesota cannot fully backfill expected federal Medicaid losses, but can use state tools to reduce harm and should press Republicans to identify what services they would cut instead.

Transcript Highlights:

• And one last thing on numbers, FDA said. regulations for Salmonella several years ago, actually over
• thousand or five hundred dozen of them. a week, you're trying to fall under that three thousand of FDA
• FDA guidelines. No CDC guidelines had to be followed.
• No FDA, no consent and all of this is still present in our federal laws.

Bills: SB500, SB719, SB912, SB1232, SB1467, SB1777, SB1864, SB2023, SB2119, SB2458

Keywords: SB 500, Texas adoption law, Family Code, DFPS, Department of Family and Protective Services, child-placing agency, prospective adoptive parents, adoption records, confidential information, nondisclosure agreement, child history report, health history, social history, educational history, genetic history, termination of parental rights, permanency plan, single source continuum contractor, privacy, redaction

Transcript Highlights:

• However, the time that we began covering these drugs, there was only one approved by the FDA.
• /c><00:41:37.800> approved<00:41:38.200> by<00:41:38.359> the<00:41:38.680> FDA
• <00:41:39.240> since<00:41:39.480> that only one approved by the FDA since that only
• one approved by the FDA since that time<00:41:39.839> the<00:41:39.960> list<00:41:40.160

Keywords: 919, house, all

Summary: Minnesota Management and Budget presented the February 2025 budget and economic forecast, with Commissioner Aon Campbell, State Economist Anthony Becker, and Budget Director Anam Mingi outlining updated revenue, spending, and long-term balance projections. The state’s FY 2026-27 general fund outlook remains positive but weaker than in November, with an ending balance of $456 million, down $160 million from the prior forecast. Looking ahead, the planning years FY 2028-29 show a projected deficit of just under $6 billion, driven largely by spending growth outpacing revenues. Officials emphasized that discretionary inflation is a major factor in the forecast, but also noted that those amounts are not automatically appropriated and would require legislative action. Becker said the national outlook has changed since November, with higher expected inflation, higher interest rates for longer, and slower growth in later years. He highlighted uncertainty around tariffs, trade policy, immigration policy, federal spending, and possible changes to tax and debt-ceiling policy, all of which could affect Minnesota’s economy and revenues. Minnesota’s labor market remains tight, with low unemployment and rising wages, and the revenue forecast was revised upward overall for FY 2026-27, including higher income and sales tax receipts, though corporate tax revenue was slightly lower than previously projected. Mingi said projected general fund spending is up $79 million in FY 2026-27 and $960 million in FY 2028-29 compared with November. The largest increases are in education and health and human services, especially due to inflation, higher pupil counts, special education costs, long-term care, and higher Medical Assistance spending. She noted that higher utilization of weight-loss drugs also raises Medicaid costs, and that a smaller assumed bonding bill helps offset some debt service costs. The commissioner and staff repeatedly warned that federal policy changes, especially possible Medicaid reductions, pose a major risk; they said Minnesota could face billions in lost federal funding, including a potential $2.4 billion hit if the enhanced Medicaid match for adults without children were eliminated. No votes or legislative actions were taken in the presentation.

Transcript Highlights:

• The FDA standards are, bar none, extremely high for our manufacturers to have to meet 10 to 12 years
• So we have one of the best stellar safety FDA agencies, I believe, and that's very important.
• If not for the FDA, and you ask, would we still have the same drug market?
• staff because the FDA has a shortage and they are not able to review the applications as quickly.
• So if anything, I would hope that FDA would be funded further to... And patients are waiting.

Keywords: 1185, senate, all

Keywords: 1189, house, all